GlassScriptPhysician profile
Matthew Edward Certain
NPI 1760669865
$6,361.72
in general payments reported to CMS, 2019-2025
43 companies · $1,733 in 2025
The $1,733 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $474 · 2021: $906 · 2022: $974 · 2023: $663 · 2024: $938 · 2025: $1,733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,333.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $762.65 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $733.31 | 2019-2025 | Camzyos, Eliquis |
| Stryker Corporation | $572.50 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $492.17 | 2019-2025 | |
| Boston Scientific Corporation | $386.67 | 2019-2025 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.07 | 2019-2025 | Jardiance |
| Amgen INC. | $313.35 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $287.46 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $279.28 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Glaxosmithkline, LLC. | $256.14 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.62 | 2019-2024 | Lifevest |
| Abiomed | $208.91 | 2019-2025 | Impella |
| Medtronic, INC. | $128.90 | 2021-2025 | Complete Se Vascular, Linq II |
| Pfizer INC. | $128.52 | 2019-2025 | |
| Biosense Webster, INC. | $125.00 | 2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $125.00 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Cvrx, INC. | $124.99 | 2021-2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $97.66 | 2020-2022 | |
| Philips North America LLC | $73.09 | 2022-2025 | Extended Holter, (5091) Amb Mon & Diag Und |
| Amarin Pharma, INC. | $69.39 | 2019-2020 | |
| Baxter Healthcare | $69.09 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Abbott Laboratories | $63.82 | 2021-2025 | Amplatzer Amulet |
| Sanofi-Aventis U.S. LLC | $47.88 | 2023-2024 | |
| Kowa Pharmaceuticals America, INC. | $42.05 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.37 | 2021-2025 | |
| Novo Nordisk INC | $34.30 | 2022-2023 | Rybelsus, Ozempic |
| Alnylam Pharmaceuticals INC. | $31.46 | 2021 | |
| Medtronic Vascular, INC. | $26.36 | 2019-2020 | |
| Braemar Manufacturing, LLC | $24.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.15 | 2022 | |
| Avinger INC. | $21.18 | 2022 | |
| Inspire Medical Systems, INC. | $21.03 | 2025 | Inspire |
| Medtronic USA, INC. | $16.87 | 2019 | |
| Irhythm Technologies, INC. | $16.69 | 2024 | Zio Xt Patch, Zio Monitor |
| Lexicon Pharmaceuticals, INC. | $16.04 | 2023 | Inpefa |
| Portola Pharmaceuticals, LLC | $15.77 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.88 | 2019 | |
| Penumbra, INC. | $14.35 | 2023 | Indigo System |
| Medicure Pharma INC. | $14.29 | 2021 | |
| Aegerion Pharmaceuticals, INC. | $14.02 | 2019 | |
| Opsens INC. | $13.57 | 2019 | |
| Bard Peripheral Vascular, INC. | $12.88 | 2023 | Rotarexs 6 F X 135 Cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Certain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.